QuantAbundanciaAbundância, quantificada.

Hoje Bolhas Universo Watchlists Portfólios ETFs Correlação Playbook Artigos Pesquisa Alertas Notícias Bots Sobre

Tradução PT-BR em revisão — relate erros à @AbundanciaCapX.

Resumo diário

Um email por dia · alertas + rotações de bolhas · grátis durante a beta.

Sobre Artigos Alertas Pesquisa Apoiar ♡Avisos legais Termos Privacidade API Seguir no X

Ações US · Fechamento diário · Atualizado todas as noites 22:30 Paris

Not investment advice. QuantAbundancia is educational research only. Nothing on this site is a recommendation to buy, sell, or hold any security. Past performance does not guarantee future results. Full disclosures.

We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.

Notícias

Apenas manchetes de alto sinal — eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

4,328 signal articles · 51 in last 24h · 19,049 total before filter · latest 52m ago

51last 24h

1675last 7d

314🟢 bullish (7d)

171🔴 bearish (7d)

136publishers

All 🌍 Macro302 📊 Earnings679 🤝 M&A113 ⚖️ Regulatory18 🚀 Product16 📈 Analyst24

✕ clear all filtersticker: LCIDsentiment: neutralSentiment:

MarketBeat3d agoneutral

Lucid Diagnostics Q1 Earnings Call Highlights

Lucid Diagnostics (NASDAQ:LUCD) reported first-quarter 2026 EsoGuard test volume above its pre-Medicare target range, while management said it continues to await a Medicare local coverage determination and is expanding efforts with the Department of Veterans Affairs, commercial payers and health sys

bullish

neutral

bearish

show all (incl. clickbait)

LCID